
Profitability, historical returns, and peer comparisons.
According to Cencora, Inc.’s latest financial reports and current stock price. The company's current ROE is 115.76%. This represents a change of 296.55% compared to the average of 29.19% of the last 4 quarters.
The mean historical ROE of Cencora, Inc. over the last ten years is 109.21%. The current 115.76% ROE has changed 6.00% with respect to the historical average. Over the past ten years (40 quarters), COR's ROE was at its highest in in the June 2021 quarter at 769.51%. The ROE was at its lowest in in the December 2022 quarter at -269.32%.
Average
109.21%
Median
98.85%
Minimum
-803.00%
Maximum
689.46%
Discovering the peaks and valleys of Cencora, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.02%
Maximum Annual ROE = 689.46%
Minimum Annual Increase = -216.47%
Minimum Annual ROE = -803.00%
| Year | ROE | Change |
|---|---|---|
| 2026 | 94.64% | -8.17% |
| 2025 | 103.06% | -55.89% |
| 2024 | 233.63% | -30.12% |
| 2023 | 334.35% | -141.64% |
| 2022 | -803.00% | -216.47% |
| 2021 | 689.46% | 106.65% |
| 2020 | 333.64% | 1.02% |
| 2019 | 29.71% | -47.46% |
| 2018 | 56.55% | 181.65% |
| 2017 | 20.08% | -70.06% |
The current ROE of Cencora, Inc. (COR) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
143.78%
5-year avg
-7.46%
10-year avg
109.21%
Cencora, Inc.’s ROE is greater than McKesson Corporation (-1423.16%), greater than Cardinal Health, Inc. (-59.73%), less than Henry Schein, Inc. (13.13%), less than Shanghai Pharmaceuticals Holding Co., Ltd (6.64%), less than Sinopharm Group Co. Ltd. (8.33%), less than 111, Inc. (23.64%), less than Accendra Health, Inc. (63.40%), less than Sigma Healthcare Limited (14.34%),
| Company | ROE | Market cap |
|---|---|---|
| -1423.16% | $124.55B | |
| -59.73% | $60.65B | |
| 13.13% | $9.83B | |
| 6.64% | $5.26B | |
| 8.33% | $6.71B | |
| 23.64% | $25.72M | |
| 63.40% | $21.18M | |
| 14.34% | $32.09B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cencora, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cencora, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Cencora, Inc.'s ROE?
How is the ROE calculated for Cencora, Inc. (COR)?
What is the highest ROE for Cencora, Inc. (COR)?
What is the 3-year average ROE for Cencora, Inc. (COR)?
What is the 5-year average ROE for Cencora, Inc. (COR)?
How does the current ROE for Cencora, Inc. (COR) compare to its historical average?